Call us at (888) 828-2206. We'll help answer any questions you may have.
Blinatumomab is an anti-CD19/anti-CD3 bi-specific T cell engager that is approved to treat acute lymphoblastic leukemia and being studied for use in other indications.
There are no resources, links or videos to display for this treatment.
You can give us a call at (888) 828-2206 or create your account to add this treatment to your list of favorites. We'll send you alerts when this treatment is updated.
Create My Account